NCT00083590

Data

{
  "briefSummary": "The present study will evaluate the safety and efficacy of the Chinese herb huperzine A in the treatment of Alzheimer's disease (AD) in a randomized controlled trial of its effect on cognitive function.",
  "completionDate": "2007-11",
  "conditions": [
    "Alzheimer Disease"
  ],
  "enrollmentCount": 150,
  "enrollmentType": "ESTIMATED",
  "nctId": "NCT00083590",
  "phase": "PHASE2",
  "sponsorId": "national-institute-on-aging-nia",
  "startDate": "2004-04",
  "status": "COMPLETED",
  "studyType": "INTERVENTIONAL",
  "title": "A Multi-Center, Double-Blind, Placebo-Controlled Therapeutic Trial to Determine Whether Natural Huperzine A Improves Cognitive Function",
  "url": "https://clinicaltrials.gov/study/NCT00083590"
}

History in this collection

1. addedv1.0.0Jun 12, 2026this version